These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7437228)
1. Pharmacokinetics of tubocurarine administered by combined i.v. bolus and infusion. Ramzan MI; Shanks CA; Triggs EJ Br J Anaesth; 1980 Sep; 52(9):893-9. PubMed ID: 7437228 [TBL] [Abstract][Full Text] [Related]
2. Studies in man with a constant-rate infusion of tubocurarine. Shanks CA; Ramzan MI; Triggs EJ Anaesth Intensive Care; 1979 Aug; 7(3):209-14. PubMed ID: 495928 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of d-tubocurarine with surgery involving salvaged autologous blood. Shanks CA; Avram MJ; Ronai AK; Bowsher DJ Anesthesiology; 1985 Feb; 62(2):161-5. PubMed ID: 3970367 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of d-tubocurarine during hypothermia in the cat. Ham J; Miller RD; Benet LZ; Matteo RS; Roderick LL Anesthesiology; 1978 Nov; 49(5):324-9. PubMed ID: 736287 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Sheiner LB; Stanski DR; Vozeh S; Miller RD; Ham J Clin Pharmacol Ther; 1979 Mar; 25(3):358-71. PubMed ID: 761446 [TBL] [Abstract][Full Text] [Related]
6. Tolerance and upregulation of acetylcholine receptors follow chronic infusion of d-tubocurarine. Hogue CW; Ward JM; Itani MS; Martyn JA J Appl Physiol (1985); 1992 Apr; 72(4):1326-31. PubMed ID: 1592722 [TBL] [Abstract][Full Text] [Related]
7. The disposition of intravenous doxapram in man. Clements JA; Robson RH; Prescott LF Eur J Clin Pharmacol; 1979; 16(6):411-6. PubMed ID: 527638 [TBL] [Abstract][Full Text] [Related]
8. Effect of sodium nitroprusside on the biophase concentration of D-tubocurarine at the neuromuscular junction. Chang P; Geh SL Clin Exp Pharmacol Physiol; 1986 May; 13(5):433-6. PubMed ID: 3742886 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of d-tubocurarine in man with and without renal failure. Miller RD; Matteo RS; Benet LZ; Sohn YJ J Pharmacol Exp Ther; 1977 Jul; 202(1):1-7. PubMed ID: 195035 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of d-tubocurarine and metocurine in the elderly. Matteo RS; Backus WW; McDaniel DD; Brotherton WP; Abraham R; Diaz J Anesth Analg; 1985 Jan; 64(1):23-9. PubMed ID: 3966648 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of tubocurarine in humans. Wingard LB; Cook DR Br J Anaesth; 1976 Sep; 48(9):839-45. PubMed ID: 183799 [TBL] [Abstract][Full Text] [Related]
12. Comparative potency and speed of onset of fazadinium and d-tubocurarine. Hussain SZ; Healy TE; Birmingham AT Acta Anaesthesiol Scand; 1979 Aug; 23(4):331-5. PubMed ID: 40380 [TBL] [Abstract][Full Text] [Related]
13. Distribution, elimination, and action of d-tubocurarine in neonates, infants, children, and adults. Matteo RS; Lieberman IG; Salanitre E; McDaniel DD; Diaz J Anesth Analg; 1984 Sep; 63(9):799-804. PubMed ID: 6465573 [TBL] [Abstract][Full Text] [Related]